Could a probiotic be used to treat inflammatory bowel disease?

Scientists have been unclear for some time about how most probiotics work. A new study has found a scientific 'design' for a probiotic that could be used to treat inflammatory bowel disease (IBD), such as Crohn's disease.

The research by academics at the University of Bristol's School of Veterinary Sciences and the School of Clinical Medicine is published online in the journal .

Most probiotics on the market, such as Lactobacillus and Bifidobacterium, are . Although probiotics have been shown to successfully maintain remission in IBD, evidence of their effectiveness in active disease is rare. The researchers have found that this is because an increase in , which happens during active IBD, inhibits the growth of , including Lactobacillus.

Iron levels increase in the intestine during inflammation, bleeding, during stress and when people are taking . Iron is critically important to the growth of most , including pathogens, and its availability is what restricts their growth. It is well known that pathogens increase growth rate by up to 8,000 times when exposed to increased levels of iron. Lactic acid bacteria are unusual as they have evolved not to require iron, and so do not increase growth rate when exposed to it.

Dr Tristan Cogan, Research Fellow in the School of Veterinary Sciences, said: "When we started our study we considered the properties that a probiotic would need to treat IBD. Most importantly, it would need to be able to survive and grow in the presence of high levels of iron and to reduce inflammation. We then worked out how to test bacteria to see whether it had these properties.

"The difficult step was finding a bacterium that had all of the properties that we wanted. Now we have found something that looks like it should work, our next step will be to test the probiotic in clinical trials."

The researchers found that a range of probiotic strains of lactic acid bacteria cannot respond to increased iron levels. The study then identified a strain, which the academics have patented, that can and showed that it has probiotic and immunomodulatory properties, and can reduce pro-inflammatory responses to pathogens associated with IBD.

The researchers suggest that iron response is the factor that prevents probiotics from being useful in treating disease, and that their bacterium could be a novel probiotic treatment for active intestinal disease.

More information: Identification and characterisation of an iron-responsive candidate probiotic, Jennifer R. Bailey, Christopher S.J. Probert and Tristan A. Cogan, PloS ONE, published 19 October 2011.

Related Stories

Promising probiotic treatment for inflammatory bowel disease

Jan 20, 2010

Bacteria that produce compounds to reduce inflammation and strengthen host defences could be used to treat inflammatory bowel disease (IBD). Such probiotic microbes could be the most successful treatment for IBD to date, ...

Probiotic bacteria could help treat Crohn's disease

Mar 31, 2011

New research suggests that infection with a probiotic strain of E. coli bacteria could help treat an reduce the negative effects of another E. coli infection that may be associated with Crohn's disease. Researchrs from the ...

Scientists discover technique to help 'friendly bacteria'

Sep 21, 2007

There is currently a great deal of interest in the health-associated properties of probiotics, also known as ‘beneficial’ or ‘friendly’ bacteria, and prebiotics, the food needed for the growth of probiotic when inside ...

Probiotic without effect against Salmonella

Apr 19, 2010

Many tourists travelling abroad go down with diarrhoea, which can be caused by Salmonella. While probiotics are often cited as the solution to various stomach problems, the probiotic, Lactobacillus plantarum has no effect ...

Recommended for you

Asthma risk varies with ethnic ancestry among Latinos

Oct 07, 2014

Native American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom ...

Asthma vaccine discovery

Oct 06, 2014

With asthma now affecting up to one in four New Zealand children, the researchers say this is a promising step in the challenge to understand and control asthma.

Phthalates heighten risk for childhood asthma

Sep 17, 2014

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used ...

User comments